Jonathan J Mazelsky Appointed to the BOD of Insulet Corporation
Jay Mazelsky: “Insulet has built a strong category-leading business based on Omnipod’s unique AID system, clinical evidence and real-world outcomes, and I am truly inspired by the Company’s relentless commitment to reduce the burden of diabetes.
June 25, 2026